(Q37973813)

26 August 2017

title

Drug policy and the public good: evidence for effective interventions (English)

1 reference

26 August 2017

1 reference

Thomas Babor

2

0 references

John Strang

object named as

John Strang

1

0 references

Keith Humphreys

6

object named as

Keith Humphreys

1 reference

26 August 2017

Jonathan Caulkins

3

1 reference

26 August 2017

Benedikt Fischer

4

1 reference

26 August 2017

David Foxcroft

5

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

379

1 reference

26 August 2017

issue

9810

1 reference

26 August 2017

page(s)

71-83

1 reference

Extent of illicit drug use and dependence, and their contribution to the global burden of disease

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

The effects of cocaine and heroin price on drug-related emergency department visits

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

An empirical analysis of imprisoning drug offenders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

The War on Drugs: Methamphetamine, Public Health, and Crime

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Evaluating explanations of the Australian 'heroin shortage'.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Impacts of federal precursor chemical regulations on methamphetamine arrests

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Impact of US and Canadian precursor regulation on methamphetamine purity in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Assessment of a Concentrated, High-Profile Police Operation. No Discernible Impact on Drug Availability, Price or Purity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Changes in the initiation of heroin use after a reduction in heroin supply

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Problem-Oriented Policing, Deterrence, and Youth Violence: An Evaluation of Boston's Operation Ceasefire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Towards a national model for managing impaired driving offenders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Is 24/7 sobriety a good goal for repeat driving under the influence (DUI) offenders?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Setting the standard for recovery: Physicians' Health Programs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Is the drug court model exportable? The cost-effectiveness of a driving-under-the-influence court

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Increasing deaths from opioid analgesics in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Mechanisms of prescription drug diversion among drug-involved club- and street-based populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Sources of prescription drugs for illicit use

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Changes in illicit opioid use across Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Prescription opioid use, misuse, and diversion among street drug users in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Effect of the requirement for triplicate prescriptions for benzodiazepines in New York State

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Trends in opiate-related deaths in the United Kingdom and Australia, 1985-1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): analyses using OD4 index in England and Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

School-based prevention for illicit drugs' use

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Interventions for prevention of drug use by young people delivered in non-school settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

The effectiveness of a school-based substance abuse prevention program: 18-month follow-up of the EU-Dap cluster randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

How effective is drug abuse resistance education? A meta-analysis of Project DARE outcome evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Effects of a universal classroom behavior program in first and second grades on young adult problem outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Brief motivational intervention at a clinic visit reduces cocaine and heroin use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Brief, personality-targeted coping skills interventions and survival as a non-drug user over a 2-year period during adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Deterioration over time in effect of Motivational Interviewing in reducing drug consumption and related risk among young people.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

The effectiveness of motivational interviewing delivered by youth workers in reducing drinking, cigarette and cannabis smoking among young people: quasi-experimental pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Personality-targeted interventions delay uptake of drinking and decrease risk of alcohol-related problems when delivered by teachers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

The need for values: science and art in alcohol harm reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Methadone maintenance at different dosages for opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Oral naltrexone maintenance treatment for opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Therapeutic communities. Enhancing retention in treatment using "Senior Professor" staff.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Treatment process in the therapeutic community: associations with retention and outcomes among adolescent residential clients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

The relationship between the Dimensions of Change Instrument and retention in therapeutic community treatment: the moderating influence of time in treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Therapeutic communities vs methadone maintenance. A prospective controlled study of narcotic addiction treatment: design and one-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Comparing the impact of standard and abbreviated treatment in a therapeutic community. Findings from the district of Columbia treatment initiative experiment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Relapse outcomes in a randomized trial of residential and day drug abuse treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Evaluating substance abuse treatment process models: I. Changes on proximal outcome variables during 12-step and cognitive-behavioral treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

A meta-analysis of voucher-based reinforcement therapy for substance use disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Contingency management for treatment of substance use disorders: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Contingency management for treatment of substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

An experimental intervention with families of substance abusers: one-year follow-up of the focus on families project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Intensive referral to 12-Step self-help groups and 6-month substance use disorder outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Attendance at Supervised Injecting Facilities and Use of Detoxification Services

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

How well do international drug conventions protect public health?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

A framework for public health action: the health impact pyramid.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961674-7

7 January 2021

10.1016/S0140-6736(11)61674-7

Identifiers

DOI

1 reference

26 August 2017

1 reference